Exercise Response After Revalidation in Cancer Patients

Universitair Ziekenhuis Brussel191 enrolled

Overview

This study regarding oncological patients for rehabilitation after specific cancer therapy involves three aims: (1) to evaluate the predictive value of myocardial work parameters on the improvement of exercise performance after rehabilitation, (2) to determine which echocardiographic parameters are more suitable in predicting cardiac dysfunction, and (3) to evaluate the correlation between echocardiographic parameters and fibrosis detected by cardiac magnetic resonance imaging (CMR).

Myocardial work (MW) provides an estimation of cardiac function by combining global longitudinal strain (GLS) with blood pressure values obtained non-invasively, being less load dependent than standard GLS. The investigator hypothesize that myocardial work could be a useful marker for predicting the exercise performance after chemotherapy and/or radiotherapy in oncological patients undergoing rehabilitation. Moreover, this study may provide additional information in optimal selection for rehabilitation programs.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

191

Conditions

Oncology Cardiac Toxicity

Interventions

Cardiorespiratory exercise testDIAGNOSTIC_TEST

* Cardiorespiratory exercise test to evaluate the exercise tolerance * Cardiac imaging for the assessment of the left atrium anatomy and function.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients diagnosed with cancer 2. Undergoing chemotherapy and/or radiotherapy/hormone therapy 3. Age older than 18 years old - maximum age of 90 years old 4. Willing to enter revalidation in Universitair Ziekenhuis Brussel 5. Signed consent form Exclusion Criteria: 1. Severe aortic stenosis defined as aortic valve aria under 0.6 cm2/m2 2. Supraventricular arrhythmias 3. Poor image quality for 2D and 3D echocardiography defined as the impossibility to examine of more than 2 adjacent segments 4. Resistant hypertension defined as uncontrolled blood pressure values under current European guidelines, Systolic Blood Pressure more than 140 mmHg and/or Diastolic Blood Pressure more than 80 mmHg 5. Lung cancer

Locations (1)

Universitair Ziekenhuis Brussel

Jette, Belgium

Outcomes

Primary Outcomes

Change in peak volume oxygen - VO2 (L/min)

represents the maximum oxygen consumption during incremental exercise that is measured during Cardiopulmonary Exercise test (CPET), being a measure of aerobic capacity of the subject

Time frame: change from baseline (before rehabilitation) at 15 months (after rehabilitation)

Change in the minute ventilation/carbon dioxide production (VE/VCO2) slope

this parameter shows the increase in ventilation in response to CO2 production, thus it measures the ventilatory efficiency

Time frame: change from baseline (before rehabilitation) at 15 months (after rehabilitation)

Change in the respiratory exchange ratio (RER)

represents the ratio between exhaled CO2 and inhale O2 may quantify the grade of the effort

Time frame: change from baseline (before rehabilitation) at 15 months (after rehabilitation)

Secondary Outcomes

Change in myocardial work (MW)

Myocardial work (MW) is a non-invasive, less load-dependent echocardiographic parameter obtained during standard transthoracic echography using the pressure-strain loop data. This parameter consists of the following measurements: Global constructive work (GCW) Global wasted work (GWW), Global work index (GWI), and Global work efficiency (GWE)

Time frame: change from baseline (before rehabilitation) at 15 months (after rehabilitation)

Change in health status

Self-assessment of the generic health status using the EQ-5D-5L questionnaire. This questionnaire assesses health status in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, on a five-level scale. In the evaluation part, the respondents evaluate their overall health status using the visual analogue scale (EQ-VAS) from 0 ('the worst health you can imagine') - 100 ('the best health you can imagine')

Central Contacts

Steven Droogmans, Professor

CONTACT

024776009 steven.droogmans@uzbrussel.be

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.